Scientific program ADDRMONLINE 2021
11.00 - 11.05 - Plenary opening
11.05 - 11.35 - Meet the Expert
| 11.05 - 11.35 | Meet the Expert 1: Mechanistic insights of SGLT2 inhibitors |
|---|---|
| Prof. dr. Ele Ferrannini, University of Pisa |
11.35 - 12.35 - You can choose between 3 sessions
| 11.35 – 11.47 |
Sex disparities in the quality of medication treatment among patients with type 2 diabetes M Ambroz (Groningen) |
|---|---|
| 11.47 – 11.59 |
Effectiveness of a stepped-care approach versus immediate continuous glucose monitoring-based technologies in hypoglycaemia-prone patients with type 1 diabetes (ECSPECT-HYPO) E. Serné (Amsterdam) |
| 11.59 – 12.11 |
Cost-effectiveness and cost-utility of foot temperature monitoring for preventing diabetic foot ulcer recurrence: a randomized controlled trial J.J. van Netten (Amsterdam) |
| 12.11 – 12.23 |
Androgens and Development of Post-Transplantation Diabetes Mellitus in Male Kidney Transplant Recipients: A post-hoc analysis of a prospective study S.P. Stam (Groningen) |
| 11.35 – 11.47 |
Single-cell RNA sequencing of human pancreatic islets reveals a role of pancreatic duct cells as mediator of the inflammation during the early stage of T1D A.M.G. Munoz Garcia (Leiden) |
|---|---|
| 11.47 – 11.59 |
Methylprednisolone prevents insulin dysfunction and cell death in human islets exposed to proinflammatory cytokines M. Paz Barba (Leiden) |
| 11.59 – 12.11 |
Markers of residual beta-cell function are associated with more time in euglycaemic range in type 1 diabetes C.M. Fuhri Snethlage (Amsterdam) |
| 12.11 – 12.23 |
The increase of the iron-transporting glycoprotein ceruloplasmin upon inflammatory stress is specific for the alpha cell population F.W.J. Boot (Leiden) |
| 12.23 – 12.35 |
Immunoproteasome expression correlates with beta cell immunogenicity and accelerates processing of DRiP epitopes S.Thomaidou (Leiden) |
| 12.23 – 12.35 |
Impact of the COVID-19 lockdown on behaviour, stress, anxiety and glycaemic control in patients with beta cell transplantation for type 1 diabetes C.P. Landstra (Leiden) |
| 11.35 – 11.47 |
Diabetes complications are associated with an altered inflammatory state in type 1 diabetes: a proteomics approach M. Ajie (Radboudumc) |
|---|---|
| 11.47 – 11.59 |
Supplementation of methylglyoxal in drinking water does not affect the cerebral microvasculature and cognitive function in non-diabetic mice E. Berends (Maastricht) |
| 11.59 – 12.11 |
ECG abnormalities and major adverse cardiac events in people with type 2 diabetes: The Hoorn Diabetes Care System cohort Peter P. Harms (Amsterdam) |
| 12.11 – 12.23 |
The association of serum magnesium with cardiovascular complications in type 1 and 2 diabetes L. Oost, (Nijmegen) |
| 12.23 – 12.35 |
Association between de novo lipogenesis susceptibility genes and coronary artery disease P.I.H.G. Simons (Maastricht) |
12.35 - 13.05 - Lunch break
13.05 - 14.05 - You can choose between 3 sessions
| 13.05 – 13.17 |
Effects of dapagliflozin and combination therapy with exenatide on food-cue induced brain activation in patients with type 2 diabetes: a randomized controlled trial C.C. van Ruiten (Amsterdam) |
|---|---|
| 13.17 – 13.29 |
Kidney Function Measures and Cardiovascular Outcomes in People with Diabetes: the Hoorn Diabetes Care System cohort E. Dal Canto (Amsterdam) |
| 13.29 – 13.41 |
Treatment with Semaglutide 2.4 mg Leads to Improvements in Cardiometabolic Risk Factors in the STEP 1 Trial D. Smit (Tilburg) |
| 13.41 – 13.53 |
An integrated e-health support of shared decision making and self-management (POWER2DM) for patients with diabetes mellitus and their healthcare professionals M.M. Ruissen (Leiden) |
| 13.05 – 13.17 |
Persistent pro-inflammatory effects of a single hypoglycaemic event in humans with and without type 2 diabetes J.I.P. van Heck (Nijmegen) |
|---|---|
| 13.17 – 13.29 |
Habitual intake of dietary dicarbonyls is associated with higher insulin sensitivity and lower odds of type 2 diabetes: The Maastricht Study K. Maasen (Maastricht) |
| 13.29 – 13.41 |
Gestational Diabetes Mellitus perturbes offspring glucose excursion at young adult age K. Hribar (Groningen) |
| 13.41 – 13.53 |
Novel biomarkers for glycaemic deterioration in type 2 diabetes: an IMI RHAPSODY study R.C. Slieker (Leiden) |
| 13.53 – 14.05 |
Development of a new Phosphorus Magnetic Resonance Technique to detect NAD-metabolites in skeletal muscle J. Mevenkamp (Maastricht) |
| 13.05 – 13.17 |
Three weeks of time restricted eating improves fasting glucose in type 2 diabetes patients but does neither increase nocturnal fat oxidation nor insulin sensitivity C. Andriessen, (Maastricht) |
|---|---|
| 13.17 – 13.29 |
Effect of lowering branched-chain amino acid levels in patients with type 2 diabetes using sodium-phenylbutyrate E. Phielix (Maastricht) |
| 13.29 – 13.41 |
Context of physical activity matters for risk of type 2 diabetes J.H.P.M. van der Velde (Leiden) |
| 13.41 – 13.53 |
Cadmium, Active Smoking and Renal Function Deterioration in Patients with Type 2 Diabetes M.M. Oosterwijk (Almelo) |
14.05 - 15.05 - You can choose between 3 sessions
| 14.05 – 14.17 |
Seven weeks of oral histidine supplementation improves glycemic control in type 2 diabetes patients M.V. Warmbrunn (Amsterdam) |
|---|---|
| 14.17 – 14.29 |
Sex disparities in treatment transitions after metformin initiation among patients with type 2 diabetes M.P Oktora (Groningen) |
| 14.29 – 14.41 |
Sustaind improvement of glycaemic outcomes in people with type 1 diabetes one year into the COVID-19 pandemic N.Ali (Nijmegen) |
| 14.41 – 14.53 |
Older age, polypharmacy, and low systolic blood pressure are associated with more hypotension-related adverse events in patients with type 2 diabetes treated with antihypertensives M. Ambroz (Groningen) |
| 14.05 – 14.17 |
Associations among treatment targets, social determinants of health and health care utilisation in Dutch people with type 2 diabetes and mental disorders : results of a linked observational dataset E.A. Nieuwenhuijse (Den Haag) |
|---|---|
| 14.17 – 14.29 |
In patients with obesity, higher levels of psychological stress are associated with lower levels of the insulin-sensitizer FGF21 S. Kuckuck and R. Lengton (Rotterdam) |
| 14.29 – 14.41 |
“I am my own doctor”: a qualitative study of the perspectives and decision-making process of Muslims with diabetes on Ramadan fasting S. Bouchareb, (Amsterdam) |
| 14.41 – 14.53 |
Momentary Assessment of Type 1 Diabetes patient’s Experiences in Glucose Variability and Mood in Real life (MERITS): First findings M. de Wit (Amsterdam) |
| 14.05 – 14.17 |
Distinct associations of plasma methionine and cysteine with fat depots: CODAM and The Maastricht Study E.C. Tore (Maastricht) |
|---|---|
| 14.17 – 14.29 |
A novel in vitro model of metabolically-activated human macrophages for studying adipocyte-macrophage cross-talk during obesity J.M. Lambooij (Leiden) |
| 14.29 – 14.41 |
Pregestational hyperglycemia associates with lower offspring survival rates and accelerates maternal NAFLD development in mouse model for gestational diabetes A.J.C. Tol (Groningen) |
| 14.41 – 14.53 |
Acute vagal nerve stimulation enhances hepatic glucose uptake in anaesthetized rats C.W. Hoornenborg (Groningen) |
| 14.53 – 15.05 |
Diet-induced Weight Loss Lowers Plasma Complement C3 via Reduction of Visceral Adipose Tissue: a Randomized Controlled Trial in Abdominally Obese Men S. Jin (Maastricht) |
15.05 - 15.35 - Award Session
| 15.05 – 15.35 |
Prof. dr. J. Terpstra Award Prof. dr. Bastiaan de Galan |
|---|---|
|
Dr. F. Gerritzen Prijs Dr. Esther Phielix |
15.35 - 16.05 - Meet the Expert
| 15.35 - 16.05 | Intestinal bacteria for type 1 diabetes |
|---|---|
| Prof. dr. Max Nieuwdorp, Amsterdam UMC |
16.05 - 17.00 - Closing and best meeting abstracts
| 16.05 – 17.00 |
A single hypoglycaemic event drives a prolonged inflammatory response in individuals with and without type 1 or type 2 diabetes C.E.M. Verhulst (Nijmegen) |
|---|---|
|
A common variant in the ketohexokinase gene is associated with fructosuria and cardiometabolic outcomes A.M Buziau (Maastricht) |
|
|
ER-mitochondria cross-talk during stress activates innate immune response in beta-cell and contributes to immune cell recruitment S. Vig (Leiden) |
|
|
Towards a GMP-Compliant Protocol for the Differentiation of Human Pluripotent Stem Cells to Beta-like Cells for the Treatment of Type 1 Diabetes B. Rajaei (Leiden) |
17.00 - Closing
MAIN SPONSORS
SPONSORS
